Abstract
Atrial fibrillation is a common arrhythmia associated with significant morbidity, including angina, heart failure, and stroke. Medical therapy remains suboptimal, with significant side effects and toxicities, and a high recurrence rate. Catheter ablation or modification of the atrioventricular node with pacemaker implantation provides rate-control but exposes patients to the hazards associated with implantable devices and does nothing to reduce the risk for stroke. Pulmonary vein antrum isolation offers a nonpharmacologic means of restoring sinus rhythm, thereby eliminating the morbidity of atrial fibrillation and the need for antiarrhythmic drugs.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 163-178 |
| Number of pages | 16 |
| Journal | Cardiology clinics |
| Volume | 27 |
| Issue number | 1 |
| DOIs | |
| State | Published - Feb 1 2009 |
| Externally published | Yes |
Keywords
- Antiarrhythmic drugs
- Atrial fibrillation
- Atrioventricular node ablation
- Catheter ablation
- Pulmonary veins
- Rate control
- Rhythm control
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Fingerprint Dive into the research topics of 'Catheter Ablation of Atrial Fibrillation'. Together they form a unique fingerprint.
Cite this
Callahan IV, T. D., Di Biase, L., Horton, R., Sanchez, J., Gallinghouse, J. G., & Natale, A. (2009). Catheter Ablation of Atrial Fibrillation. Cardiology clinics, 27(1), 163-178. https://doi.org/10.1016/j.ccl.2008.09.004